My Personal CFO LLC’s Gilead Sciences GILD Stock Holding History

My Personal CFO LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-61	Closed	-$5.24K	–	366
2022 Q4	$5.24K	Buy	+61	New	+$4.83K	﹤0.01%	361

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

My Personal CFO LLC's GILD Position: Q1 2023 in Review

My Personal CFO LLC sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 61 shares — an estimated $5.24K sold.

My Personal CFO LLC first reported a position in GILD in Q4 2022 and held it in 1 quarter. The position peaked at $5.24K in Q4 2022. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

My Personal CFO LLC reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
My Personal CFO LLC sold 61 Gilead Sciences shares in Q1 2023, an estimated $5.24K.
My Personal CFO LLC first reported a position in Gilead Sciences in Q4 2022 and held it in 1 quarter.
My Personal CFO LLC's Gilead Sciences position peaked at $5.24K in Q4 2022.
1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on My Personal CFO LLC's 13F filing for Q1 2023, filed 21 Apr 2023.